Parente F, Bianchi Porro G
Gastrointestinal Unit, L. Sacco Hospital, Milan, Italy.
Scand J Gastroenterol Suppl. 1994;206:3-7. doi: 10.3109/00365529409091413.
The antisecretory activity of nizatidine, an H2-receptor antagonist, has been extensively investigated in man both by quantitative acid secretory tests and by means of 24-h continuous ambulatory pH monitoring. Studies have shown that nizatidine is a potent inhibitor of basal, nocturnal and stimulated acid secretion. Particular modalities of nizatidine administration, such as early evening intake with supper or morning dosing, have been recently defined. Further studies are needed to clarify if rebound nocturnal acid hypersecretion may develop after abrupt withdrawal of nizatidine or if tolerance may develop during prolonged administration.
H2受体拮抗剂尼扎替丁的抗分泌活性已通过定量酸分泌试验和24小时连续动态pH监测在人体中进行了广泛研究。研究表明,尼扎替丁是基础、夜间和刺激胃酸分泌的有效抑制剂。最近已明确了尼扎替丁给药的特殊方式,如晚餐时傍晚服用或早晨给药。需要进一步研究以阐明突然停用尼扎替丁后是否会出现夜间酸分泌反跳性高分泌,或者长期给药期间是否会产生耐受性。